Home | Careers | BI | Contact us


Neopharm’s Anti-Bribery & Anti-Corruption Policy

April 29, 2019

Neopharm’s Anti-Bribery & Anti-Corruption Policy Neopharm recognizes the detrimental impact bribery and corruption has on society. Neopharm is committed to conducting its business throughout the world with integrity, the highest ethical standards, and in compliance…

PLMA trade show

February 22, 2017

DPL will participate for the 16th time in PLMA Trade show – The biggest show for Private…

Neopharm Group acquired DPL – Disposable Hygienic Products

April 19, 2016

Neopharm Group, had recently acquired  DPL – Disposable Hygienic Products LTD . The acquisition is a part on the Neopharm’s strategy to expand its operations and consolidate its position asa leading consumer products company in…

Prima Biomed and Neopharm Group Execute Final Agreement For CVAC...

March 3, 2014

Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima”, the “Company”) is pleased to announce that it has finalized an agreement with Neopharm Group (“Neopharm”) for an exclusive license (“License”) to market and sell CVac™, a…

Next Page →

Home | About Us | Companies | Partnering | Research | Corporate Citizenship | Careers | Newsroom | Contact | Legal Notice

All Rights reserved, Neopharm Group, Israel | Design by: VAZA | Developed by: The Shark Lady